(Q33816861)

29 July 2017

1 reference

title

Movement disorders in Alzheimer's disease: more rigidity of definitions is needed (English)

1 reference

29 July 2017

0 references

1 reference

Kurlan R

1

1 reference

29 July 2017

Richard IH

series ordinal

2

1 reference

29 July 2017

Papka M

series ordinal

3

1 reference

29 July 2017

Marshall F

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

15

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

24-29

1 reference

The extrapyramidal disorder of Alzheimer's disease.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Extrapyramidal signs in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Pathological correlates of extrapyramidal signs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Extrapyramidal signs, primitive reflexes and frontal lobe function in senile dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Measurement and prediction of functional capacity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Extrapyramidal signs in patients with probable Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Tourette's syndrome and 'PANDAS': will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

The extrapyramidal system: an inquiry into the validity of the concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Interrater reliability of extrapyramidal signs in a group assessed for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Human walking and higher-level gait disorders, particularly in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Drug-induced alzheimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Parkinson's disease in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Lewy body disease: can we diagnose it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Pick's disease, frontotemporal dementia, and Pick complex: emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a G-->T change at position 2149 of the amyloid precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Practical therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val→Ile mutation in the amyloid precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Clinical subtypes of dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Heterogeneity in dementia of the Alzheimer type: evidence of subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Revision of the international classification of diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200001%2915%3A1%3C24%3A%3AAID-MDS1006%3E3.0.CO%3B2-X

10.1002/1531-8257(200001)15:1<24::AID-MDS1006>3.0.CO;2-X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference